TY - JOUR
T1 - ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
AU - Bischoff, Stephan C.
AU - Bager, Palle
AU - Escher, Johanna
AU - Forbes, Alastair
AU - Hébuterne, Xavier
AU - Hvas, Christian Lodberg
AU - Joly, Francisca
AU - Klek, Stansilaw
AU - Krznaric, Zeljko
AU - Ockenga, Johann
AU - Schneider, Stéphane
AU - Shamir, Raanan
AU - Stardelova, Kalina
AU - Bender, Darija Vranesic
AU - Wierdsma, Nicolette
AU - Weimann, Arved
N1 - Funding Information:
This guideline was financed by ESPEN, the European Society for Clinical Nutrition and Metabolism .
Publisher Copyright:
© 2023 European Society for Clinical Nutrition and Metabolism
PY - 2023/3
Y1 - 2023/3
N2 - The present guideline is an update and extension of the ESPEN scientific guideline on Clinical Nutrition in Inflammatory Bowel Disease published first in 2017. The guideline has been rearranged according to the ESPEN practical guideline on Clinical Nutrition in Inflammatory Bowel Disease published in 2020. All recommendations have been checked and, if needed, revised based on new literature, before they underwent the ESPEN consensus procedure. Moreover, a new chapter on microbiota modulation as a new option in IBD treatment has been added. The number of recommendations has been increased to 71 recommendations in the guideline update. The guideline is aimed at professionals working in clinical practice, either in hospitals or in outpatient medicine, and treating patients with IBD. General aspects of care in patients with IBD, and specific aspects during active disease and in remission are addressed. All recommendations are equipped with evidence grades, consensus rates, short commentaries and links to cited literature.
AB - The present guideline is an update and extension of the ESPEN scientific guideline on Clinical Nutrition in Inflammatory Bowel Disease published first in 2017. The guideline has been rearranged according to the ESPEN practical guideline on Clinical Nutrition in Inflammatory Bowel Disease published in 2020. All recommendations have been checked and, if needed, revised based on new literature, before they underwent the ESPEN consensus procedure. Moreover, a new chapter on microbiota modulation as a new option in IBD treatment has been added. The number of recommendations has been increased to 71 recommendations in the guideline update. The guideline is aimed at professionals working in clinical practice, either in hospitals or in outpatient medicine, and treating patients with IBD. General aspects of care in patients with IBD, and specific aspects during active disease and in remission are addressed. All recommendations are equipped with evidence grades, consensus rates, short commentaries and links to cited literature.
UR - https://www.scopus.com/pages/publications/85147829554
U2 - 10.1016/j.clnu.2022.12.004
DO - 10.1016/j.clnu.2022.12.004
M3 - Article
C2 - 36739756
AN - SCOPUS:85147829554
SN - 0261-5614
VL - 42
SP - 352
EP - 379
JO - Clinical Nutrition
JF - Clinical Nutrition
IS - 3
ER -